Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vivo

Currently viewing:

Administrative data

Endpoint:
in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
Type of information:
experimental study
Remarks:
source of read across
Adequacy of study:
key study
Study period:
From the 02nd February to the 23th March, 1989
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
test procedure in accordance with generally accepted scientific standards and described in sufficient detail

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1989

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
Version / remarks:
adopted on 26th May, 1983
Qualifier:
according to guideline
Guideline:
EU Method B.12 (Mutagenicity - In Vivo Mammalian Erythrocyte Micronucleus Test)
GLP compliance:
yes
Type of assay:
mammalian germ cell cytogenetic assay

Test material

Constituent 1
Reference substance name:
Similar Substance 01
IUPAC Name:
Similar Substance 01

Test animals

Species:
mouse
Strain:
Swiss
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Charles River Wiga GmbH, Sulzfeld, FRG
- Age at study initiation: ca. 8 weeks
- Weight at study initiation: males 27 - 32 g; females 20 - 25 g
- Fasting period before study: withheld the night before dosing until 4 hours after administration.
- Diet: standard laboratory animal diet (RMH-B); certificate of analysis performed.
- Water: tap water; certificate of analysis performed.
- Accomodation: in groups of 5 per sex in polycarbonate cages.
- Acclimation: at least 6 days under laboratory conditions.
- Identification: by unique cage number and a mark on the tail.

ENVIRONMENTAL CONDITIONS
- Temperature: 21 ± 3 °C
- Humidity: 40 - 70 %
- Air changes: 7.5 ACH
- Photoperiod: 12 hours dark

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
- Vehicle: Milli-RO water.
- Concentration of test material in vehicle: 4000 mg/kg b.w., single dose.
- Amount of vehicle: 10 ml/kg b.w.
- Sampling time: 24, 48 and 72 hours.
Details on exposure:
Single oral dose of 4000 mg/kg b.w.
Duration of treatment / exposure:
Bone marrow was sampled at 24, 48 and 72 hours after dosing for both treated and control animal groups. Groups A and B were dosed with 4000 and 2000 mg/kg b.w. substance respectively, and did not show any signs of reaction to the treatment.
Concentration higher than 4000 could not be assessed due to aggregation of test article in suspension.
Doses / concentrations
Dose / conc.:
4 000 mg/kg bw/day (nominal)
No. of animals per sex per dose:
5 males and 5 females.
Control animals:
yes, concurrent vehicle
Positive control(s):
Yes, cyclophosphamide.
- Route of administration: oral gavage.
- Dose: single dose at 50 mg/kg b.w. dissolved in 0.9 % NaCl in Milli-RO water.
- Sampling time: 48 hours after treatment.

Examinations

Tissues and cell types examined:
Bone marrow and erythrocytes.
Details of tissue and slide preparation:
CRITERIA FOR DOSE SELECTION
A pilot study was performed on 3 males and 3 females per each dose group (five).

DETAILS OF SLIDE PREPARATION
Both femurs were flushed with 2 ml of foetal calf serum. The cell suspension was collected and centrifuged at 1000 rmp for 5 minutes. A drop of the cell suspension was placed on a slide which was previously cleaned (24 hours immersed in a 1:1 mixture of 96 % ethanol/ether). The preparations were then air-dried and thereafter fixed for 5 min in 100 % methanol and air-dried overnight. Two slides were prepared per animal.
- Staining: stained for 3 minutes in undiluted May-Grunwald solution followed by 2 minutes in May Grunwald solution diluted 1:1 with Sorensen buffer pH 6.8. Thereafter slides were rinsed and stained for 25 minutes in 5 % (v/v) Giemsa solution in Sorensen buffer pH 6.8. The preparations were rinsed for 1 minute in running tap-water and blotted dry between filter paper.

METHOD OF ANALYSIS
Slides were scored at a magnification of 1000 x. The number of micronuclei was counted in 1000 polychromatic erythrocytes. The ratio polychromatic to normochromatic erythrocytes was determined by counting and differentiating the first 1000 erythrocytes at the same time. Averages and standard deviations were calculated.
Evaluation criteria:
Test substance is considered negative if:
- None of the tested concentrations or sampling times showed a statistically significant (p < 0.05) increase in the incidence of micronuclei neither in the combined data for both sexes nor in the data for male or female groups alone.

Results and discussion

Test results
Sex:
male/female
Genotoxicity:
negative
Toxicity:
no effects
Vehicle controls validity:
valid
Positive controls validity:
valid
Additional information on results:
RESULTS OF DEFINITIVE STUDY
- Induction of micronuclei: no.
- Statistical evaluation: incidence of micronuclei in the control animals was found to be in the range of historical data of the performing laboratory. Positive control showed a statistical significant increase in the number of micronuclei.

Any other information on results incl. tables

Mean number of micronuclei

Sex Group Treatment Dose [mg/kg b.w.] Sampling time [h] Micronuclei no. per 1000 polychromatic erythrocytes  Ratio polychromatic / normochromatic erythrocytes
Mean SD Mean SD
M A Vehicle - 24 0.0 0.0 1.50 0.27
B Vehicle - 48 0.0 0.0 1.27 0.44
C Vehicle - 72 0.0 0.0 1.31 0.17
D Test item 4000 24 0.0 0.0 1.46 0.89
E Test item 4000 48 0.6 0.9 1.06 0.16
F Test item 4000 72 0.0 0.0 1.64 0.45
G  Positive control 50 48 8.6 2.1 0.44 0.12
F A Vehicle - 24 0.0 0.0 2.23 0.86
B Vehicle - 48 0.4 0.9 1.94 1.45
C Vehicle - 72 0.0 0.0 1.38 0.40
D Test item 4000 24 0.2 0.4 1.33 0.77
E Test item 4000 48 0.2 0.4 1.39 0.41
F Test item 4000 72 0.0 0.0 1.26 0.21
G  Positive control 50 48 8.0 0.7 0.40 0.11

Applicant's summary and conclusion

Conclusions:
The test substance can be considered as not mutagenic in the Mouse Micronucleus Test, under the experimental conditions of the test.
Executive summary:

The substance was tested in the Micronucleus Test in mice, according to the method and procedures outlined into the OECD guideline 474. Three groups, each comprising 5 males and 5 females, received a single oral dose of 4000 mg/kg body weight. Bone marrow was sampled at 24, 48 and 72 hours after dosing. Corresponding vehicle treated groups served as negative controls. Bone marrow from a positive control group, treated with a single oral dose of cyclophosphamide (CP) at 50 mg/kg body weight, was harvested at 48 hours after dosing only. The test substance was found to respond negatively in the Micronucleus Test, whereas the positive control substance (CP) produced a statistically significant increase in the incidence of micronuclei in polychromatic erythrocytes.

Conclusion

The test substance can be considered as not mutagenic in the Mouse Micronucleus Test, under the experimental conditions of the test.